Experts develop equitable quality measures to improve lupus care by 2030

Leaders of a project to develop and implement equitable new quality measures for lupus care by the end of the decade will present their work at ACR Convergence 2023, the American College of Rheumatology’s annual meeting.

FDA Approves First Interchangeable Biosimilars to Aflibercept for AMD

The FDA approved the first interchangeable biosimilars to aflibercept (Eylea) to treat macular degeneration, according to an announcement from the agency. As interchangeable biosimilars, aflibercept-jbvf

May 21, 2024

Paxlovid is not fully accessible to those who need it most: the immunocompromised

The pandemic is over for most of the world. But for the 2.7% of adults in the United States who are immunocompromised, it isn’t. I’m

September 27, 2023

Ratio Therapeutics secures funds for cancer radiotherapies

Share this article Ratio Therapeutics develops next-generation precision radiopharmaceuticals for solid tumours. Credit: Lightspring/Shutterstock.com. Ratio Therapeutics has secured $50m in a Series B financing round,

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.